NCT07528131

Brief Summary

PET and PET/CT imaging remains promising, and with current and further improvements, PET and PET/CT imaging may make the diagnosis and evaluation of gastric cancer more standardized and accurate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 22, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 22, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 22, 2024

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

April 7, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 14, 2026

Completed
Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

April 7, 2026

Last Update Submit

April 7, 2026

Conditions

Gastric Cancer

Keywords

FDGPET/Ct, SUVmax, Gastric Cancer,

Outcome Measures

Primary Outcomes (1)

  • diagnosis ,staging ,assessment of treatment response and assessment of recurrence

    assess the value of SUVmax in every detected lesion in relation to the liver uptake and compare if this lesion deteced in other investigation

    12months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The Current Retrospective and Prospective study was conducted among 50 histologically confirmed Gastric Cancer patients ,mean age of the studied cases was 57.58 ± 10.26 years and ranged between (35-77) years. Moreover, the study included 29 males (58%) and 21 females (42%).

You may qualify if:

  • Patients diagnosed as Gastric Cancer on surgically resected specimens.
  • Patients with gastric and extragastric metastasis.
  • Patients with gastric cancer either operated or not

You may not qualify if:

  • Patients with second malignancy (Double primary).
  • Patient without proven pathology of Cancer Stomach.
  • Severely ill patient (patient with disturbed conscious level, or couldn't lay supine during the imaging).
  • Uncontrolled diabetic patient with blood glucose level more than 200mg\\dl.
  • Pregnant women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sara Saber Ahmed

Sohag, 82524, Egypt

Location

MeSH Terms

Conditions

Stomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesStomach Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer of Nuclear Medicine

Study Record Dates

First Submitted

April 7, 2026

First Posted

April 14, 2026

Study Start

September 22, 2023

Primary Completion

September 22, 2024

Study Completion

September 22, 2024

Last Updated

April 14, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

the individual participant data will not be made available to other researchers to maintain patient confidentiality.

Locations

EG(1)